News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
37,784 Results
Type
Article (2415)
Company Profile (39)
Press Release (35330)
Section
Business (14108)
Career Advice (77)
Deals (2074)
Drug Delivery (8)
Drug Development (4091)
Employer Resources (10)
FDA (428)
Job Trends (761)
News (20116)
Policy (1051)
Tag
Academia (143)
Alliances (3466)
Alzheimer's disease (43)
Antibody-drug conjugate (ADC) (14)
Approvals (430)
Bankruptcy (11)
Best Places to Work (475)
Biosimilars (10)
Biotechnology (29)
Breast cancer (15)
Cancer (104)
Career advice (64)
CAR-T (12)
Cell therapy (35)
Clinical research (3141)
Collaboration (79)
Compensation (36)
COVID-19 (179)
C-suite (21)
Data (82)
Diagnostics (464)
Duchenne muscular dystrophy (9)
Earnings (4159)
Events (5936)
Executive appointments (75)
FDA (465)
Funding (67)
Gene editing (13)
Gene therapy (13)
GLP-1 (59)
Government (146)
Healthcare (702)
Infectious disease (184)
Inflammatory bowel disease (11)
Intellectual property (9)
IPO (985)
Job creations (290)
Job search strategy (62)
Layoffs (36)
Legal (212)
Lung cancer (15)
Manufacturing (17)
Medical device (304)
Medtech (304)
Mergers & acquisitions (1141)
Metabolic disorders (27)
Neuroscience (81)
NextGen: Class of 2025 (352)
Non-profit (153)
Northern California (291)
Obesity (13)
Opinion (14)
Patents (14)
People (5594)
Phase I (1353)
Phase II (1581)
Phase III (837)
Pipeline (45)
Postmarket research (30)
Preclinical (582)
Radiopharmaceuticals (12)
Rare diseases (17)
Real estate (419)
Regulatory (790)
Research institute (142)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (20)
Southern California (284)
Startups (487)
United States (1384)
Vaccines (24)
Weight loss (9)
Date
Last 7 days (59)
Last 30 days (172)
Last 365 days (2551)
2025 (327)
2024 (2610)
2023 (2858)
2022 (3752)
2021 (4048)
2020 (3471)
2019 (2061)
2018 (1565)
2017 (1799)
2016 (1624)
2015 (1834)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (43)
Arizona (14)
Asia (1846)
Australia (295)
California (663)
Canada (120)
China (32)
Colorado (15)
Connecticut (9)
Europe (3789)
Florida (39)
Illinois (13)
Indiana (26)
Kansas (12)
Maryland (22)
Massachusetts (234)
Minnesota (14)
New Jersey (48)
New York (38)
North Carolina (80)
Northern California (291)
Ohio (24)
Pennsylvania (31)
South America (40)
Southern California (284)
Texas (54)
Washington State (36)
37,784 Results for "anixa biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Anixa Biosciences CEO Provides Letter to Shareholders
January 21, 2025
·
6 min read
Press Releases
Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum
February 11, 2025
·
3 min read
Press Releases
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
February 18, 2025
·
4 min read
Press Releases
Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
February 14, 2025
·
4 min read
Drug Development
Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences, Inc. today announced that it has treated the sixth patient in the ongoing Phase 1 clinical trial.
June 24, 2024
·
5 min read
Press Releases
Anixa Biosciences’ Chairman & CEO Dr. Amit Kumar Featured on CW39’s H-Town Live to Discuss the Future of Breast Cancer Prevention
February 4, 2025
·
3 min read
Press Releases
Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
November 22, 2024
·
4 min read
Press Releases
Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
December 4, 2024
·
3 min read
Drug Development
Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced that treatment has commenced for the fifth patient in its ongoing Phase 1 clinical trial of its novel chimeric antigen receptor T-cell (CAR-T) therapy for ovarian cancer.
May 21, 2024
·
4 min read
Biotech Bay
Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
Anixa Biosciences, Inc., a clinical-stage biotechnology company focused on the treatment and prevention of cancer, announced that it has entered into a joint development agreement with Cleveland Clinic to develop novel vaccines for various cancer types.
May 8, 2024
·
5 min read
1 of 3,779
Next
